Lapas attēli
PDF
ePub

PRICE OF DRUG.

Before the war began the patent drug was sold at $4 per dose, which is approximately $3,500 per pound, and speculatively it has brought as high as $35 per dose. While the price of the product is not fixed at this time by the commission, the right to fix prices is retained, and a price of $1 per dose to the Army and Navy, $1.25 per dose for hospitals, and $1.50 per dose for physicians are the prices at which some, at least, of the licensees have stated that they intend to offer the licensed drug.

The enormous shortage of supply of this important product will immediately be relieved, and the article placed in the hands of the Government, the hospitals, and the medical profession at a price lower than ever before.

(From 1 Official Bulletin, Washington, Nov. 30, 1917.)

EXECUTIVE ORDER REVOKINg Power and AUTHORITY IN Designated OFFICERS UNDER THE TRADING-WITH-THE-ENEMY ACT.

By virtue of the power and authority vested in me by "an act to define, regulate, and punish trading with the enemy, and for other purposes," approved October 6, 1917, I hereby make the following orders and rules and regulations:

SECRETARY OF THE TREASURY.

I. I hereby revoke the authority and power vested in the Secretary of the Treasury by Section XI of the Executive order of October 12, 1917, to issue licenses to send, take, or transmit out of the United States any letter or other writing, book, map, plan, or other paper, picture, or any telegram, cablegram, or wireless message, or other form of communication intended for or to be delivered, directly or indirectly, to an enemy or ally of enemy, in any way relating to letters patent, or registration of trade-mark, print, label, or copyright, or to any applications therefor; and no such license shall be granted until further order.

FEDERAL TRADE COMMISSION.

II. I hereby revoke the power and authority vested in the Federal Trade Commission by Section XVII of the Executive order of October 12, 1917, to issue licenses to any citizens of the United States, or any corporation organized within the United States, to file or prosecute applications in the country of an enemy or ally of enemy

for letters patent or for registration of trade-mark, print, label, or copyright, and to pay any fees or agents' fees in connection therewith, or to pay to any enemy or ally of enemy any tax, annuity, or fee in relation to patents, trade-marks, prints, labels, and copyrights; and no such license shall be granted until further order.

THE WHITE HOUSE,

WOODROW WILSON.

11 April, 1918.

UNLICENSED USE BY THE UNITED STATES OF PATENTED INVENTIONS— COMPENSATION SECURED BY SUIT IN COURT OF CLAIMS.

[PUBLIC NO. 182-65TH CONGRESS.]

[H. R. 10854.]

An act making appropriations for the naval service for the fiscal year ending June 30, 1919, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled:

[blocks in formation]

The act entitled "An act to provide additional protection for the owners of patents of the United States, and for other purposes," approved June 25, 1910, shall be, and the same is hereby, amended to read as follows, namely:

That whenever an invention described in and covered by a patent of the United States shall hereafter be used or manufactured by or for the United States without license of the owner thereof or lawful right to use or manufacture the same, such owner's remedy shall be by suit against the United States in the Court of Claims for the recovery of his reasonable and entire compensation for such use and manufacture: Provided, however, That said Court of Claims shall not entertain a suit or award compensation under the provisions of this act where the claim or compensation is based on the use or manufacture by or for the United States of any article heretofore owned, leased, used by, or in the possession of the United States:

Provided further, That in any such suit the United States may avail itself of any and all defenses, general or special, that might be pleaded by a defendant in an action for infringement, as set forth in title 60 of the Revised Statutes, or otherwise:

And provided further, That the benefits of this act shall not inure to any patentee who, when he makes such claim, is in the employment or service of the Government of the United States, or the assignee of any such patentee; nor shall this act apply to any device discovered or invented by such employee during the time of his employment or service.

[blocks in formation]

HARVARD LAW SCHOOL LIBRARY

This book is due on or before the date stamped below. Books must be returned to the Circulation Desk from which they were borrowed. Nonreceipt of an overdue notice does not exempt the user from a fine.

JUL 19 1999

« iepriekšējāTurpināt »